Aminoacyl-tRNA synthetases prevent mistranslation, or genetic code ambiguity, through specialized editing reactions. Mutations that disrupt editing in bacteria adversely affect cell growth and viability, and recent work in the mouse supports the idea that translational errors caused by an editing defect lead to a neurological disease-like phenotype. To further investigate the connection of mistranslation to cell pathology, we introduced an inducible transgene expressing an editing-deficient valyl-tRNA synthetase into mammalian cells. Introducing mistranslation precipitated a disruption of cell morphology and membrane blebbing, accompanied by activation of caspase-3, consistent with an apoptotic response. Addition of a noncanonical amino acid that is misactivated, but not cleared, by the editing-defective enzyme exacerbated these effects. A special ambiguity-detecting sensor provided direct readout of mistranslation in vivo, supporting the possibility that decreased translational fidelity could be associated with disease.
Introduction
Connections between specific human diseases and aminoacyl-tRNA synthetases (AARSs) illustrate the emerging awareness of the importance of these enzymes in disease pathology [1, 2] . Although the mechanism of disease causation is not known, we hypothesize that defects in activities idiosyncratically associated with specific synthetases, such as editing, could be responsible for pathological mutations. In a related vein, potential links between faulty translation and disease have been reported for specific translation factors. For example, levels of the translation initiation factor eIF-4E are elevated in human cancers and are linked to conversion of cells into malignant states in culture [3] [4] [5] . In one study, NIH/3T3 cells exhibited a transformed phenotype after overexpression of eIF-4E. Tumors developed when the transformed cell lines were injected into nude mice. In another investigation, profound neuromuscular problems were observed in mice that carry a deleterious mutation in translation elongation factor eEF1A2 [6] [7] [8] . Recently, protein synthesis was again highlighted in the human neurodegenerative disease VWM/CACH (vanishing white matter/childhood ataxia with central hypomyelination). This disease is connected to mutations in translation factor eIF-2B [9, 10] .
These examples illustrate that maintaining control, and possibly fidelity, in translation may be far more sensitive and subtle than previously thought. With that in mind, we sought to determine whether inducing mistranslation via mutation of a component of the translation apparatus, i.e., an aminoacyl-tRNA synthetase, could be connected to an apparent phenotype in mammalian cells. Many tRNA synthetases have editing activities to correct errors of aminoacylation and prevent mistranslation, or genetic code ambiguity [11] [12] [13] . At least in bacterial cells, these activities are critical for optimal cell growth and, under some circumstances, cell viability [14, 15] . Thus, disruption of tRNA synthetase editing functions may also have broad consequences in mammalian cells. The significance of the editing function traces back to the highly accurate genetic code algorithm relating each amino acid to specific nucleotide triplets found in messenger RNAs (mRNAs). This algorithm is established in aminoacylation reactions catalyzed by AARSs, in which each amino acid is linked to the 2 0 or 3 0 OH of the cognate tRNA that bears the anticodon triplet of the code that corresponds to the attached amino acid [16] [17] [18] . To maintain high accuracy levels [13, 19, 20] , certain AARSs that are forced to discriminate between sterically similar amino acids have a second active site that clears, or edits, incorrectly charged amino acids [21] [22] [23] [24] . If a mutation affects the editing function of one of these enzymes, production of mischarged tRNAs results in misincorporation of amino acids that can, in principle, create pools of statistical, heterogeneous proteins [25] [26] [27] .
Recently, mice harboring a single missense mutation in the editing domain of alanyl-tRNA synthetase (AlaRS) were shown to exhibit severe ataxia accompanied by degeneration of Purkinje cells in the brain [28] . The mutation in murine AlaRS produced a partial defect in the ability of the enzyme to clear mischarged Ser-tRNA Ala in vitro. Although the editing defect was only partial, a strong phenotype was seen in the mouse. In particular, ataxia and Purkinje cell degeneration were accompanied by the upregulation of cytoplasmic protein chaperones and induction of the unfolded protein response.
Here, we report results of a laboratory-based system to directly study mistranslation within mammalian cells that harbor an editing-deficient tRNA synthetase. We chose a different enzyme that has a potent activity for preventing mistranslation, ValRS. This choice enabled us to investigate whether the kind of effects seen in mouse were idiosyncratic to AlaRS or more general. Also, by working with a mammalian cell system in culture, we could more closely control the production of the editing-defective enzyme and set up a specialized system to give a direct readout of mistranslation. The results obtained support the hypothesis that pathological states can arise from mistranslation in mammalian cells, caused by a single missense mutation in the editing domain of a tRNA synthetase and, in addition, that such mutations can dominate over the wild-type allele.
Moreover, the severity of the cellular response appears to be correlated with the degree of mistranslation that is induced.
Results

Structural Implications for Creating EditingDeficient ValRS
The editing reaction of ValRS occurs at a distinct second active site located in an insertion, the connective polypeptide 1 (CP1), that is conserved throughout archaea, bacteria, and eukaryotes [29] [30] [31] . Point mutations in CP1 of Escherichia coli ValRS render the enzyme incapable of efficient hydrolysis of mischarged tRNAs, such as Thr-tRNA Val , which are then released for mRNA decoding [15, 25] . At the same time, presumably because the site for editing is distal to the active site for aminoacylation, these editing-defective mutants are fully competent for aminoacylation. In the presence of a DvalS null background in E. coli, each tested editingdefective mutant ValRS adversely affected bacterial cell viability when cells were grown in the presence of elevated amounts of a noncognate amino acid that is misactivated by ValRS (i.e., Thr, L-a-aminobutyric acid [aAbu]). The magnitude of the editing defect measured in vitro directly correlated with the degree of sensitivity to noncognate amino acid addition that was observed in vivo.
T222P E. coli ValRS was the most editing defective of the previously studied enzymes. Significantly, T222 in E. coli ValRS is highly conserved through evolution ( Figure 1A) . (Of the available ValRS sequences, only a few bacterial species, including Thermus thermophilus and some species of Deinococcus, have replaced this highly conserved T with the isosteric V. Interestingly, T also appears at this position in other class I editing-proficient aminoacyl-tRNA synthetases [IleRS and LeuRS] that contain the CP1 insertion [32, 33] .) Recently, the structure of the T. thermophilus ValRS editing domain complexed with a Thr-AMP analog (N-[L-threonyl]sulfamoyl)adenosine was solved [34] . This structure provided the opportunity to rationalize the severe phenotype of the T222P substitution in E. coli ValRS, and to visualize the corresponding substitution in a mammalian ValRS (T535P Mus musculus ValRS), indicating its potential effects on hydrolytic editing. Using the structure of the T. thermophilus CP1 insertion as a scaffold, a model of the M. musculus ValRS [35] active site for editing was generated by homology modeling by using the program 3D-PSSM (three-dimensional position-specific scoring matrix) [36, 37] . Side chains were constructed with SCWRL [38] . A PSSM E-value of 0.00339 was assigned to the model and indicated >95% confidence in the prediction. In this model, a T is placed at the position corresponding to T535 in M. musculus ValRS, replacing V214 in T. thermophilus ValRS ( Figure 1B ). In this model, the residue corresponding to T535 is close to the bound Thr-AMS and helps to form the binding pocket for the misactivated adenylate or the threonyl moiety of ThrtRNA Val . When a P replaces T535, assuming no structural rearrangement, the misactivated substrate is partly occluded ( Figure 1C ). (More likely, the introduced P would produce a significant distortion of the binding pocket.) This analysis provided a structural rationale for the potency of the previously studied T222P substitution of E. coli ValRS and supported the idea that a similar substitution in M. musculus ValRS would be deleterious to editing.
Initial Characterization of T535P M. musculus ValRS
Wild-type and T535P M. musculus ValRS were overexpressed in E. coli, isolated, and assayed for aminoacylation activity. Both proteins were functional for aminoacylation (Figure 2A ) of bulk mammalian tRNA isolated from bovine liver. That the aminoacylation activities of these enzymes were similar shows that introduction of the T535P mutation introduced no large-scale structural changes that would interfere with the active site for aminoacylation. This result is consistent with prior work with the E. coli ortholog and further established that the two active sites, separated by w30 Å , are functionally independent. Next, the ability of wild-type and T535P ValRS to hydrolyze Thr-tRNA Val was investigated ( Figure 2B ). For this purpose, the necessary large amounts of pure
Val were generated by using E. coli T222P ValRS to mischarge endogenous purified E. coli tRNA Val (for reasons of technical constraints and convenience, mammalian Thr-tRNA Val was not prepared). While E. coli tRNA
Val is a poor substrate for aminoacylation by M. musculus ValRS, the mammalian enzyme can still distinguish Thr from Val in the context of E. coli tRNA Val and can hydrolyze mischarged Thr-tRNA Val , as was observed for the wild-type enzyme here. (A similar lack of preference in tRNA selection by the hydrolytic editing site has also been observed for PheRS from Saccharomyces cerevisiae. In this case, the cytoplasmic PheRS cannot aminoacylate mitochondrial tRNA
Phe , yet it readily deacylates mischarged mitochondrial Tyr-tRNA Phe in trans [39] .) In contrast, T535P ValRS was severely compromised for clearing Thr-tRNA Val . Thus, as seen for the E. coli enzyme, the T / P substitution at the analogous position in ValRS greatly reduced its hydrolytic editing activity.
Expression of Wild-Type and Editing-Defective ValRS in Mammalian Cells
To test the effects of a ValRS editing deficiency in vivo, an inducible transgene of both wild-type and T535P ValRS was constructed. Mammalian ValRS, like other AARSs of higher eukaryotes, has additional domains that are appended to the highly conserved core enzyme that is the ortholog of prokaryotic ValRSs [40, 41] (the core itself has w32 % sequence similarity between E. coli and M. musculus ValRS). These additional domains are dispensable (for aminoacylation) and are contained within a 295 amino acid polypeptide fused to the N-terminal side of the core enzyme [42] [43] [44] [45] [46] . Treatment with elastase selectively cleaves w250 amino acids from the N-terminal side of full-length human ValRS [44, 46] , suggesting that, under some circumstances, a truncated form may occur naturally in mammalian cells. The most N-terminal of these appended domains is unique to ValRSs of higher eukaryotes and is required to facilitate the formation of a 5 subunit 700 kDa complex between ValRS and elongation factor 1H [44, 47, 48] . In addition to aminoacylation activity, this complex functions in translation to sustain mRNA-dependent polypeptide synthesis in the presence of EF-2 and mRNA-dependent binding of charged tRNA to ribosomes. Because cells specifically expressing T535P (but not wild-type) ValRS were unstable, the transgene was constructed to encode a protein in which residues 1-295 were removed from the N terminus to create ValRS D (a transgene similar to that used by Park et al. to overexpress human ValRS in HEK293 cells [49] ), thereby allowing us to generate mischarged tRNA Val in mammalian cells. We speculate that, with full-length T535P ValRS, Thr-tRNA
Val is more efficiently transferred to the EF-1H complex and the ribosome than is the case with the T535P ValRS D . This increase in efficiency would result in more mistranslation and greater toxicity.
Constructs encoding wild-type and T535P mutant ValRS D were transfected into NIH/3T3 mouse fibroblast cells and, after induction for 24 hr, yielded soluble protein. Stably transfected cell lines capable of expressing each of the constructs were generated, with both transgene constructs yielding a single cell line. Production of recombinant ValRS D in these cell lines was dependent on induction by mifepristone (MFP), and there was no basal expression detectable (by western blot) in the absence of MFP ( Figure 3A) . The cell lines encoding wildtype and T535P ValRS D expressed protein at similar levels, with slightly more ValRS D seemingly produced in the wild-type cell line at the same concentration of the MFP inducer. (Figure 3B) . After 24-48 hr of induction, many cells were no longer attached to the culture flask and instead were found floating in the media. While the cells that remain attached appear to retain contact inhibition, and grow as a monolayer, the gapped regions seen between clusters of cells remain prominent over time so that a confluent monolayer cannot be achieved. Many cells were observed to exhibit altered morphologies characterized by cell contraction and membrane blebbing (as indicated by white arrows). These morphologies are hallmarks of apoptosis. In contrast, induction of the stable cell line encoding wild-type ValRS D caused only a subtle cell-shape change ( Figure 3B ). Similar phenotypic changes were observed upon induction of fulllength wild-type ValRS in a generated stable cell line, showing that the phenotypic effect cannot be attributed to overexpression of truncated ValRS.
Introduction of an Editing-Deficient ValRS
To investigate further whether phenotypic differences in cells expressing wild-type versus T535P ValRS D were caused by genetic code ambiguity introduced by errors of aminoacylation, expression in stably transfected NIH/ 3T3 cell lines was induced in media supplemented with the natural metabolite a-Abu (concentrations ranged from low micromolar to millimolar). ValRS activates a-Abu (K M elevated w100-fold in relation to Val) to produce a-Abu-tRNA
Val [50] ( Figure 3C ). Uninduced cells were not visibly affected by the addition of a-Abu (up to 2 mM). As mentioned above, cells expressing wildtype ValRS showed a subtle phenotypic change upon induction. However, no further changes were observed when cells were incubated in media supplemented with a-Abu, up to concentrations of 2 mM. In contrast, the phenotype observed upon induction of T535P ValRS D was exacerbated dramatically by the introduction of a-Abu to the media ( Figure 3C ). The number of cells remaining attached to the tissue culture dish correlated inversely with the concentration of a-Abu, with the least amount of viable cells present at the highest a-Abu concentrations. Additionally, more numerous incidences of membrane blebbing were observed when cells were treated with a-Abu (white arrows). This striking phenotype demonstrates that, in mammalian cells, genetic code ambiguity caused by a single point mutation in a specific tRNA synthetase severely affects cell morphology and viability.
Prolonged endoplasmic reticulum stress induced by accumulation of unfolded/misfolded proteins leads to cell death via apoptosis. This process is highlighted by an increase in polyubiquitinylation of the unfolded Figure 3E ), thus suggesting that an accumulation of misfolded/unfolded proteins may be linked to the apoptotic-like response.
Expression of Editing-Deficient ValRS Induces a Caspase-3-Mediated Apoptotic Response
The execution phase of programmed cell death or apoptosis is characterized by marked changes in cell morphology. One of the most notable of these phenotypic transformations is the effect of membrane blebbing that we observed in cells after induction of T535P ValRS D . To explore the link between expression of T535P ValRS D and apoptosis, the activation of caspase-3 (a marker used to identify cells undergoing apoptosis) was investigated. Produced as an inactive zymogen, caspase-3 undergoes proteolytic activation during apoptosis that, in turn, converts the enzyme to a functional cysteine protease [51] . Cleavage by activated caspase-3 was monitored by measuring release of a linked fluorophore upon cleavage of a caspase-3-specific peptide (Ac-DEVD-AMC).
A significant increase in fluorescence resulting from activation of caspase-3 was detected when the fluorogenic peptide was incubated with lysates from induced cells expressing T535P ValRS D compared with lysates from uninduced cells ( Figure 3D ). Mirroring the trend observed in morphology transformation, when cells expressing T535P ValRS D were treated with a-Abu, the levels of activated caspase-3 increased considerably over those found in induced, untreated cells. In contrast, no significant activation of caspase-3 was observed in induced cells expressing wild-type ValRS D ( Figure 3D , inset) compared to uninduced cells, regardless of the presence or absence of a-Abu. Also, when the T535P ValRS D cell line was not induced, but was treated with a-Abu, only a small increase in activated caspase-3 was observed over untreated cells. These results show that genetic code ambiguity in a mammalian cell, induced by the prolonged expression of an editingdeficient ValRS D , results in the initiation of an apoptotic response that involves caspase-3 activation. Encouraging increased misincorporation by treatment with a-Abu (a noncognate amino acid that can be misactivated by ValRS) exacerbated this response.
Construction of a Mistranslation-Detecting Sensor
To demonstrate genetic code ambiguity in cells expressing the editing-deficient T535P ValRS D , we designed a method to directly monitor the misincorporation of T at V codons. This method was based on the enhanced form of green fluorescent protein (EGFP) from the Pacific Northwest jellyfish Aequorea victoria. EGFP has a T at position 65 of its consensus sequence (T-Y-G) that is essential for enhanced fluorescence activity [52] [53] [54] . Changes in fluorescence occur upon introduction of substitutions within this consensus sequence. (Substitution of T for wild-type S65 accounts for the enhanced fluorescence and red-shifted excitation maxima of EGFP [55] .) We hypothesized that introduction of V65 would alter the fluorescent profile of GFP, allowing detection of misincorporation of T at the position 65 V codon ( Figure 4A ).
To test this concept, a gene encoding T65V EGFP was transiently transfected into NIH/3T3 cells in culture. In contrast to cells expressing wild-type EGFP, after 48 hr those expressing T65V exhibited, at most, a minimal fluorescent signal ( Figures 4B and 4C) . Expression of T65V EGFP was verified by immunodetection with a labeled antibody to GFP (Alexa 568-GFP). This result showed that the lack of fluorescence of T65V EGFP was due to elimination of chromophore formation, not to a lack of the presence of mutant protein. (This observation was consistent with the minimal background fluorescent signal also observed in lysates of cells expressing T65V EGFP that were subjected to quantitative analysis of the emission spectra at 509 nm [excitation at 488 nm] [data not shown].) Thus, this system provides a way to monitor T misincorporation as a recovery of fluorescence.
Mistranslation Observed in Cells Expressing Editing-Deficient ValRS
To examine the effects of the ValRS transgenes on Thr misincorporation, the T65V EGFP biosensor was transiently transfected into NIH/3T3 cells stably transfected with inducible forms of either wild-type or T535P ValRS D . After T65V transfection (allowing time for cellular recovery), ValRS transgenes were induced and incubated for 12-18 hr to allow for build up of newly synthesized proteins. In cells expressing wild-type ValRS D , the minimal T65V EGFP fluorescence did not increase ( Figures 5A and 5B) . In contrast, cells expressing T535P ValRS D showed a clear gain in EFGP fluorescence ( Figures 5A and 5C ). This gain is consistent with misincorporation of T at position 65 thereby restoring the chromophore consensus sequence. The presence of comparable amounts of T65V EGFP in cells harboring either the gene for wild-type or T535P ValRS D was confirmed by probing with an antibody to GFP (anti-GFP IgG Alexa Fluor 647). This analysis showed that the increase in EGFP fluorescence resulted from the presence of the editing-defective enzyme, not from an intrinsic difference in levels of EGFP.
To provide a more quantitative measure of fluorescence recovery due to misincorporation, cells were lysed and samples were analyzed for fluorescence emission. In addition, total EGFP fluorescence for each cell sample was corrected for the amount of EGFP protein present. The fractional change in fluorescence was then calibrated by comparing T65V EGFP fluorescence for cells expressing the ValRS D transgenes versus those in which ValRS D transgene expression had not been induced. By using these two standards, a dynamic range of fluorescence emission could be established. This assay demonstrated an w16.7% 6 1.5% gain in fluorescence in cells coexpressing T535P ValRS D and T65V EGFP, a statistically significant gain ( Figure 5A ). In con-
trast, cells expressing wild-type ValRS
D did not exhibit a significant quantitative increase in T65V EGFP fluorescence (1.75% 6 2.5%). In addition to the modified consensus sequence, the EGFP protein contains 18 valines that, when substituted with Thr, may alter the folding or fluorescent properties of EGFP. Possibly, therefore, Val / Thr substitutions at any of these positions could cause local denaturation and exacerbate the loss of fluorescence. To investigate this question, we attempted to ''force'' substitution of Thr into the other valine codons of EGFP. This attempt was made via raising the exogenous Thr concentration 10-fold. In this extreme circumstance, the fractional gain in T65V fluorescence due to Thr insertion was only slightly reduced (14.4% 6 0.4%, data not shown) compared to the gain in fluorescence without increased Thr (16.7% 6 1.5%). Thus, the effect of the insertion of Thr at sites other than the target site appears to be limited.
Discussion
In comparison to what has been observed in bacteria and yeast, mammalian cells appear to be more sensitive to mistranslation. In E. coli, cell viability is only affected in cells in which the wild-type tRNA synthetase allele is knocked out and growth is carried out in the presence of a noncognate amino acid that can be mischarged by the editing-deficient enzyme [14, 15] . In Candida albicans, while introduction of ambiguity induces what appears to be a novel stress response (revealed in changes in gene expression and cellular proteome content) that is accompanied by a 50% reduction in growth rate, there is no indication of cell death [56, 57] . In contrast, in mammalian cells, expression of an editing-deficient ValRS is sufficient to cause dramatic changes in cell phenotype and the initiation of an apoptotic response. Because the mutant ValRS studied here acquired the ability to cause amino acid misincorporation, the mutation can be viewed as a gain-of-function mutation. As expected for a gain-of-function mutation, it had a dominant-negative effect over the wild-type alleles.
Previous work showed that when E. coli ValRS bearing the corresponding editing mutation (T222P) was introduced into bacteria and grown in the presence of a-Abu, global substitution (mistranslation) at Val codons occurred at a level of up to 24% (as determined by amino acid analysis). For an overexpressed individual protein, the degree of misincorporation for a given peptide ranged between 9.5% and 18% per Val codon (as determined by MALDI-mass spectrometry) [25] . In light of this, it is particularly striking that the fractional gain of 16.7 % in T65V EGFP fluorescence, which was observed in response to an editing-deficient murine ValRS in mammalian cells, falls directly within the range of misincorporation rates observed under similar conditions in bacteria. Although the fractional gain in fluorescence is not considered to directly reflect the level of Thr misincorporation occurring at all Val codons, it has to relate to the degree of Thr misincorporation occurring at Val65 of EGFP. Therefore, this number may loosely reflect the degree of global misincorporation occurring at Val codons when an editing-deficient ValRS is expressed in mammalian cells.
The observed sensitivity of mammalian cells to errors in translation raises the broader question of the mechanistic basis. Through many routes, cell and whole-organism physiology can be impacted by introduction of global changes in primary protein sequence. These routes include disruption of protein folding pathways, creation of altered proteins with newly acquired interactions, or induction of autoimmune-type responses ( Figure 6 ). During the folding process, proteins collapse into their globular native states in a manner determined by their primary amino acid sequence [58, 59] . Thus, small changes in amino acid sequence have the potential to create unfolded polypeptides or misfolded protein aggregates [60, 61] . The appearance of misfolded and/ or aggregated proteins in the endoplasmic reticulum (ER) of eukaryotic cells activates a signaling cascade (the unfolded protein response [UPR] [62, 63] ) that, when overwhelmed, can lead to cell death via apoptosis [64, 65] . In this scenario, the formation of statistical proteins leads to the initiation of the UPR and induction of an apoptotic response. The accumulation of insoluble protein aggregates is linked to many etiologically unrelated neurodegenerative disorders, pointing to what could be a potential disease-related connection [66] [67] [68] [69] [70] .
At the organism level, amino acid misincorporation could plausibly trigger an autoimmune-like response. By chemically altering tyrosine residues on the surface Release of mischarged tRNAs in a eukaryotic cell generated by an editing-deficient aminoacyl-tRNA synthetase and resulting in mistranslation could impact a variety of areas of cell physiology.
of the native form of thyroglobulin by using arsenillic or sulfanillic acid, Weigle and coworkers demonstrated that, upon injection of the conjugated proteins into rabbits, antibodies formed over time and developed crossreactivity with their own native thyroglobulin [71, 72] . Prolonged exposure to these self-antibodies resulted in thyroiditis. In principle, this phenomenon can occur when altered proteins are generated by amino acid misincorporation, that is, an immune response provoked in response to altered proteins formed through translational errors could result in the targeting of native proteins and the onset of an autoimmune-like condition. Sequence alignments demonstrate a high level of conservation in the editing domains of class I tRNA synthetases. In particular, the region into which the T535P mutation was introduced contains some of the most highly conserved residues of the CP1 domain, with key residues conserved in almost every ValRS, IleRS, and LeuRS in organisms ranging from bacteria through humans [32, 33, 73] . Although strict conservation of this sequence throughout evolution shows that strong selective pressure was exerted to retain the editing function, the importance of hydrolytic editing in vivo has only recently been demonstrated in bacteria. The work presented here provides a powerful rationale for this high level of conservation extending to mammals.
Significance
Components of the translation apparatus have been associated with several pathologies and diseases. We have investigated global effects of mistranslation in mammalian cells in culture. AARSs prevent mistranslation through specialized editing reactions that clear any tRNAs that have been aminoacylated with incorrect amino acids. Here, we mutationally disabled the editing function of a murine tRNA synthetase that normally has a potent editing activity. The mutant enzyme is incapable of clearing mischarged tRNA substrates, while, at the same time, it retains wildtype aminoacylation activity. Stable NIH/3T3 mouse fibroblast cell lines were engineered to inducibly express the transgene encoding the mutant enzyme. Prolonged induction of the editing-deficient tRNA synthetase led to a pronounced dominant-negative morphological phenotype. Phenotypic changes were characterized by cell contraction, membrane blebbing, and caspase-3 activation, consistent with an apoptotic-like response. By forcing the use of a noncanonical amino acid that is misacylated and not cleared by the editing-deficient enzyme, morphological effects were exacerbated and activation of caspase-3 was increased. To obtain a direct readout of mistranslation in vivo, a modified EGFP mRNA was expressed, which only produces fluorescent protein when mistranslation occurs. This fluorescent sensor allowed detection of mistranslation upon induction of the editingdeficient tRNA synthetase. In contrast, no fluorescent signal was seen upon induction of the wild-type tRNA synthetase. These investigations show that mistranslation can lead to mammalian cell pathologies and raises the possibility that it has a causal relationship with genetic diseases.
Experimental Procedures
Plasmid Construction An EST of w4 kb encoding a putative M. musculus ValRS was identified in an EST database (Invitrogen, clone 4971200) by searching against the published sequence [35] . For expression and purification from E. coli, the valS cDNA from clone 4917200 was subcloned into pET28a (EMD Biosciences) by using SalI and NotI to attach an N-terminal His tag upstream of the valS start codon (pLAN410). The QuickChange Site-Directed Mutagenesis Kit (Stratagene) was used to replace the ACC Thr535 codon with a CCC Pro codon (pLAN441). For generation of transgenic cell lines, the coding sequences for wild-type (WT) and T535P ValRS D were subcloned into pGene/V5-His B (Invitrogen) by using HindIII and NotI sites (pLAN438, pLAN443). For misincorporation studies, T65V EGFP was constructed by using site-directed mutagenesis on pEGFP-N1 (BD Clontech) to replace the ACC Thr65 codon with a GUG Val codon.
Molecular Modeling
Sequence of M. musculus ValRS containing the editing domain (residues M337-V1137) was submitted for fold recognition to the 3D-PSSM server (http://www.sbg.bio.ic.ac.uk/w3dpssm/). A model was generated by using homology modeling based on the structure of the T. thermophilus ValRS editing domain [34] . The model was supported by an E-value of 0.0039, corresponding to confidence in the prediction of >95%. Side chains were modeled in 3D-PSSM by SCWRL.
Aminoacylation and Deacylation Assays
WT and T535P M. musculus ValRS were purified from E. coli (details are available upon request), and concentrations were determined by the Bradford assay (BioRad) and active site titration. Aminoacylation assays were performed as previously described [22] Cell Culture Stably transfected cell lines (GeneSwitch NIH/3T3) were selected, isolated, and maintained in DMEM plus 10% fetal bovine serum, 1% penicillin/streptomycin, 2 mM L-glutamine, 50 mg/ml hygromycin, and 500 mg/ml zeomycin. Lipofectamine and Plus Reagent were used for transfections. ValRS D expression was induced with MFP (1 3 10 28 M) and was detected by immunoblotting with anti-V5-HRP mouse monoclonal antibody (cell culture reagents were purchased from Invitrogen). Monoclonal anti-polyubiquitin antibody, clone FK1 (Biomol), was used to detect polyubiquitinated proteins.
Caspase-3 Activation Assays
Assays measuring caspase-3 activation were performed with the Caspase-3 Assay Kit (BD Pharmingen) according to manufacturer's instructions. Briefly, ValRS D transgenic cell lines were treated with combinations of +/2MFP and a-Abu (100 mM) and were harvested after 24 hr. For each sample, 6 3 10 6 cells were resuspended in 100 ml lysis buffer for the assay. AMC liberation was measured with a FluoroMax-3 spectrofluorimeter (HORIBA Jobin Yvonn) (excitation at 380 nm; emission at 420-460 nm). The fractional change in fluorescence relative to uninduced cells was determined for each sample. Data represent six independent experiments done in duplicate.
Threonine Misincorporation Assays WT and T535P ValRS D cell lines were grown to w60% confluency and transfected with 2 mg pEGFP-N1 (EGFP) or pCMM149 (T65V EGFP) by using Effectene according to the manufacturer's instructions (QIAGEN). After recovery in growth media (1-2 hr), cells were prepped for either fluorescence microscopy or quantitative analysis. Fluorescence Microscopy Cells were seeded onto fibronectin-coated glass coverslips and treated with MFP for 12-18 hr. Cells were then fixed for 20 min in 2% formaldehyde/PBS, permeabilized in 0.2 % Triton X-100/PBS, and rinsed with PBS. Cells were stained with anti-GFP IgG Alexa Fluor 647 conjugate (Molecular Probes) and mounted in immunofluoresence mounting medium (MP Biomedicals). Images were acquired with a Bio-Rad (Zeiss) MRC1024 laser scanning confocal microscope. Fluorescence Spectrophotometry Cells were lysed in M-PER Reagent (Pierce), and soluble fractions were isolated. Samples were analyzed with a FluoroMax-3 spectrofluorimeter (HORIBA Jobin Yvonn) (excitation at 488 nm; emission at 507 nm). Units of EGFP per sample were determined by using Amplex Red ELISA kit #1 (Molecular Probes) utilizing an anti-GFP monoclonal antibody, JL-8 (Santa Cruz Biotechnology). HRP was detected by using Amplex Red (excitation at 570 nm; emission at 585 nm), and relative concentrations of EGFP were determined by using a standard curve based on purified EGFP protein standards. Relative EGFP levels were verified by immunoblotting with the same antibody set. Values generated were used to correct for the amount of EGFP protein present in each sample.
